Vera Therapeutics, Inc. (NASDAQ: VERA) reported Q3 EPS of ($1.26), $0.11 worse than the analyst estimate of ($1.15).

For earnings history and earnings-related data on Vera Therapeutics, Inc. (VERA) click here.